Inhibition of adaptive therapy tolerance in cancer: is triplet mitochondrial targeting the key?
Sign Up to like & getrecommendations! Published in 2023 at "Molecular Oncology"
DOI: 10.1002/1878-0261.13406
Abstract: Targeted therapies have become a mainstay in the treatment of cancer, but their long‐term efficacy is compromised by acquired drug resistance. Acquired therapy resistance develops via two phases—first through adaptive development of nongenetic drug tolerance,… read more here.
Keywords: therapy tolerance; triplet; tolerance; drug ... See more keywords